Literature DB >> 21180543

The challenge of developing new therapies for irritable bowel syndrome.

Fernando Azpiroz1, Peter J Whorwell.   

Abstract

Entities:  

Year:  2009        PMID： 21180543      PMCID： PMC3002522          DOI： 10.1177/1756283X09335638

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  11 in total

1.  Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.

Authors:  S A Müller-Lissner; I Fumagalli; K D Bardhan; F Pace; E Pecher; B Nault; P Rüegg
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

Review 2.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 3.  Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders.

Authors:  L A Houghton; P J Whorwell
Journal:  Neurogastroenterol Motil       Date:  2005-08       Impact factor: 3.598

Review 4.  Irritable bowel syndrome: diagnosis and management.

Authors:  A Agrawal; P J Whorwell
Journal:  BMJ       Date:  2006-02-04

5.  Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulceration.

Authors:  E Guthrie; F H Creed; P J Whorwell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

6.  Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.

Authors:  M Camilleri; A R Northcutt; S Kong; G E Dukes; D McSorley; A W Mangel
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

7.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

8.  Suicidal ideation in patients with irritable bowel syndrome.

Authors:  Vivien Miller; Louise Hopkins; Peter J Whorwell
Journal:  Clin Gastroenterol Hepatol       Date:  2004-12       Impact factor: 11.382

9.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

10.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.